Condition: Squamous Cell Carcinoma · Alpha Radiation · Immunocompromised · Sponsor: Alpha Tau Medical LTD.
This is a multi-center clinical study enrolling up to 28 participants. The primary objectives are to determine the objective response rate (ORR) established by the confirmed best overall response (BOR) following intratumoral administration of DaRT - Diffusing Alpha-Emitters Radiation Therapy. Secondary objectives are to: 1. Determine Progression Free Survival (PFS) up to 12 months after Alpha DaRT sources insertion. 2. Assess Overall Survival (OS) of patients treated with DaRT up to 12 months. 3. Assess Local control up to 12 months after DaRT insertion.
This description comes directly from the study's public registry record.
Liron Dimnik · +972-2-3737-210 · LironD@alphatau.com
Aviya Hoida · +972-2-3737-210 · aviyah@alphatau.com
Always discuss trial participation with your own doctor first.
| Banner Health | Gilbert, Arizona, United States | Recruiting |
| Us Dermatology Parthners | Phoenix, Arizona, United States | Recruiting |
| Alliance Dermatology | Phoenix, Arizona, United States | Recruiting |
| Integrity Research Clinical Associates | Boca Raton, Florida, United States | Not Yet Recruiting |
| Hollywood Dermatology | Hollywood, Florida, United States | Recruiting |
| Palm Beach Dermatology Group | Palm Beach, Florida, United States | Not Yet Recruiting |
| Day Star Skin Cancer Center | Poinciana, Florida, United States | Not Yet Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Not Yet Recruiting |
| Bassett Healthcare | Cooperstown, New York, United States | Recruiting |
| Hadassah Medical Center | Jerusalem, Israel | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06615635